EAG2 potassium channel with evolutionarily conserved function as a brain tumor target

Characterizing the impact of pharmacological and shRNA-mediated silencing of EAG2 in medulloblastoma.

12

Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY